GPER inhibits tumor cell growth by stimulating G2/M-phase cell cycle arrest, decreasing cyclin B expression, and promoting apoptosis in ERα-negative breast cancer cells (Wei et al., 2014). Here, ESR1 is linked to breast carcinoma.